Skip to main content
Journal cover image

Strategies to Reduce the Risk-Adverse Reproductive Outcomes Related to Hazardous Drugs.

Publication ,  Journal Article
Walton, AL; Olsen, MM
Published in: J Obstet Gynecol Neonatal Nurs
January 2026

Numerous drugs used to treat cancer and other conditions, such as lupus and rheumatoid arthritis, are teratogenic and can cause fertility impairment and reproductive toxicity; therefore, they are considered hazardous. Researchers have found that health care workers (HCWs) who are exposed to hazardous drugs on the job are at increased risk for adverse reproductive outcomes, and breastfeeding infants can be exposed to hazardous drugs through breast milk. As more of these drugs are administered, and as their use expands beyond oncology settings to long-term care facilities and the home, increased awareness of the risks they pose to HCWs is needed. In this critical commentary, we review what is known about adverse reproductive outcomes of occupational exposure to hazardous drugs, describe sources of exposure, and suggest strategies to minimize exposure.

Duke Scholars

Published In

J Obstet Gynecol Neonatal Nurs

DOI

EISSN

1552-6909

Publication Date

January 2026

Volume

55

Issue

1

Start / End Page

80 / 88

Location

United States

Related Subject Headings

  • Risk Assessment
  • Pregnancy
  • Occupational Exposure
  • Nursing
  • Infant, Newborn
  • Humans
  • Health Personnel
  • Hazardous Substances
  • Female
  • Drug-Related Side Effects and Adverse Reactions
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Walton, A. L., & Olsen, M. M. (2026). Strategies to Reduce the Risk-Adverse Reproductive Outcomes Related to Hazardous Drugs. J Obstet Gynecol Neonatal Nurs, 55(1), 80–88. https://doi.org/10.1016/j.jogn.2025.05.114
Walton, AnnMarie L., and MiKaela M. Olsen. “Strategies to Reduce the Risk-Adverse Reproductive Outcomes Related to Hazardous Drugs.J Obstet Gynecol Neonatal Nurs 55, no. 1 (January 2026): 80–88. https://doi.org/10.1016/j.jogn.2025.05.114.
Walton AL, Olsen MM. Strategies to Reduce the Risk-Adverse Reproductive Outcomes Related to Hazardous Drugs. J Obstet Gynecol Neonatal Nurs. 2026 Jan;55(1):80–8.
Walton, AnnMarie L., and MiKaela M. Olsen. “Strategies to Reduce the Risk-Adverse Reproductive Outcomes Related to Hazardous Drugs.J Obstet Gynecol Neonatal Nurs, vol. 55, no. 1, Jan. 2026, pp. 80–88. Pubmed, doi:10.1016/j.jogn.2025.05.114.
Walton AL, Olsen MM. Strategies to Reduce the Risk-Adverse Reproductive Outcomes Related to Hazardous Drugs. J Obstet Gynecol Neonatal Nurs. 2026 Jan;55(1):80–88.
Journal cover image

Published In

J Obstet Gynecol Neonatal Nurs

DOI

EISSN

1552-6909

Publication Date

January 2026

Volume

55

Issue

1

Start / End Page

80 / 88

Location

United States

Related Subject Headings

  • Risk Assessment
  • Pregnancy
  • Occupational Exposure
  • Nursing
  • Infant, Newborn
  • Humans
  • Health Personnel
  • Hazardous Substances
  • Female
  • Drug-Related Side Effects and Adverse Reactions